ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1625

Single Cell and Spatial Transcriptomics Identifies Pathogenic Drivers of Sjogren’s Disease in Humans

Blake Warner1, Thomas Pranzatelli2, Paola Perez2, Daniel Martin2, Shyh-Ing Jang2, Kalie Dominick2, Eiko Yamada2, Kevin Byrd3, Quinn Easter4, A. Darise Farris5, Christopher Lessard5, Amanda Oliver6, Raquel Bartolome-Casado6, Zohreh Khavandgar1, Sarthak Gupta7, Sarah Teichmann6, Alan Baer8 and John Chiorini2, 1National Institutes of Health, Bethesda, MD, 2NIDCR, Bethesda, MD, 3American Dental Association, Scientific Research Institute, Gaithersburg, MD, 4American Dental Association, Gaithersburg, MD, 5Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Wellcome Sanger Institute, Cambridgeshire, United Kingdom, 7National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 8Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Bioinformatics, Genomics and Proteomics, Sjögren's syndrome, T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Abstracts: Sjögren's Syndrome – Basic and Clinical Science

Session Type: Abstract Session

Session Time: 5:00PM-6:00PM

Background/Purpose: Sjogren’s Disease(SjD) is a systemic autoimmune disease characterized by exocrine dysfunction. The pathogenesis is incompletely understood, but involves gene-environment interactions leading to infiltration of immune cells and autoimmunity. Immune-epithelial crosstalk and the mechanisms driving exocrine dysfunction remain ill-defined. High throughput transcriptional analyses have broadened our understanding the etiopathogenesis of SjD. However, ‘bulk’ approaches cannot uncouple disease-specific changes in cellularity and cell-state simultaneously and lack direct spatial context. We hypothesized that single cell(sc) and spatial transcriptomics(st) approaches can directly unravel the immunopathology of SjD in the salivary glands.

Methods: scRNAseq was performed on human minor salivary glands(MSG; SjD: n=12, HV: n=17) and paired peripheral blood mononuclear cells(PBMCs; SjD: n=8, HV: n=7) to assess cellular composition and transcriptional states. MSG(SjD: n=24; HV: n=24) were sectioned onto 10X Visium slides and sequenced. Cell2location was used to analyze altered cellularity and interactions from stRNAseq datasets. Utilization of signaling pathways in sc and st datasets was assessed across annotated pathways. MSG were also used for flow cytometry, HiPlex in situ hybridization, and immunohistochemistry as confirmation.

Results: scRNAseq of MSG, but not PBMCs, exhibited profound changes in cellularity and differentially expressed genes(DEG) in SjD(Figure 1). SjD MSG had more inflammatory cells(e.g., T cells, B cells, and antigen presenting cells[APC]; and loss of seromucous cells). In SjD, many cell types’ DEG sets showed increased expression of MHC class I, B2M and HLA-B, and interferon (IFN) stimulated genes(e.g., ISG15). These phenomena were dependent on autoantibody positivity, but not focus score. In acinar cells, secretory markers(MUC7, AQP5) were significantly decreased. In T cell clusters(CD8, CD4), functional annotation analysis revealed marked activation of T cells including: ‘positive regulation of the Type I IFN response’, ‘T cell receptor signaling’, and ‘response to IFNg signaling’. PMA/ionomycin stimulation of MSG lymphocytes showed that CD8+T-cells were significantly more cytotoxic than in HV(Figure 1). Profound cellularity-dependent architectural and transcriptional changes in the glands and disease-specific cell-cell interactions(e.g., T cells:APC, T cells:acinar cells) and altered cellular neighborhoods were identified using stRNAseq(Figure 2).

Conclusion: Multiomics single cell and spatially transcriptomic approaches disentangle the complex disease-dependent tissue disorganization, cellular compositional alterations, and transcriptional cellular states in the salivary glands of SjD patients. Our findings link loss of secretory cells and gland function, with the presence of cytotoxic CD8+T-cells. Further, these results emphasize the expression modules and spatial arrangement of immune cells, and their interactions, promoting tissue damage in the salivary glands. In summary, these data pinpoint pathogenic cell populations, and their interactions, that may be directly targetable for therapeutic intervention.

Supporting image 1

Figure 1. scRNAseq and spatial transcriptomics were used to understand compositional and transcriptional alterations in SG and PBMC from SjD and nonSjD. A. UMAP and leiden clustering of ~450k cells from 29 MSG and 15 paired PBMC. B. SjD exhibits loss of secretory cells and increased in inflammatory cells (adj. q-val. *<0.05, **<0.01), as well as profound effects on per-cell gene expression (data not shown). C. Flow cytometric analysis and PMA/ionomycin stimulation confirmed increased T cell infiltration of the MSG with an emphasis on increased activated CD8IFNg-hi,CD107a+ T cell in SjD but not CD4 T cell populations.

Supporting image 2

Figure 2. stRNAseq revealed altered tissue organization at the transcriptional, cell:cell, and transcriptional level. A. Cell2location was used to infer the cellularity of spatially-resolved spots. B. Leiden clustering of spots reveals shifts in SjD (orange dotted box). Co-occurrence and neighborhood analysis reveals not only changes in cellularity and transcriptome, but that higher-order arrangement and the signaling neighborhoods of the gland are profoundly affected and emphasizes the most disease specific co-occurring cell types in SjD.


Disclosures: B. Warner, Pfizer, Astellas Bio; T. Pranzatelli, None; P. Perez, None; D. Martin, None; S. Jang, None; K. Dominick, None; E. Yamada, None; K. Byrd, None; Q. Easter, None; A. Farris, Janssen; C. Lessard, Janssen; A. Oliver, None; R. Bartolome-Casado, None; Z. Khavandgar, None; S. Gupta, None; S. Teichmann, None; A. Baer, None; J. Chiorini, None.

To cite this abstract in AMA style:

Warner B, Pranzatelli T, Perez P, Martin D, Jang S, Dominick K, Yamada E, Byrd K, Easter Q, Farris A, Lessard C, Oliver A, Bartolome-Casado R, Khavandgar Z, Gupta S, Teichmann S, Baer A, Chiorini J. Single Cell and Spatial Transcriptomics Identifies Pathogenic Drivers of Sjogren’s Disease in Humans [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/single-cell-and-spatial-transcriptomics-identifies-pathogenic-drivers-of-sjogrens-disease-in-humans/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-and-spatial-transcriptomics-identifies-pathogenic-drivers-of-sjogrens-disease-in-humans/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology